Literature DB >> 34532533

mRNA Stability Assay Using transcription inhibition by Actinomycin D in Mouse Pluripotent Stem Cells.

Madara Ratnadiwakara1, Minna-Liisa Änkö1.   

Abstract

Gene expression is regulated through multiple steps at both transcriptional and post-transcriptional levels. The net abundance of mature mRNA species in cells is determined by the balance between transcription and degradation. Thus, the regulation of mRNA stability is a key post-transcriptional event that can greatly affect the net level of mRNAs in cells. The mRNA stability within cells can be measured indirectly by analyzing the mRNA half-life following transcription inhibition, where changes in mRNA levels are assumed to reflect mRNA degradation. Determination of mRNA half-life as a measure of mRNA stability is useful in understanding gene expression changes and underlying mechanisms regulating the level of transcripts at different physiological conditions or developmental stages. The protocol described here presents the analysis of mRNA decay as a measure for determining mRNA stability after transcriptional inhibition with Actinomycin D treatment in control and SRSF3 depleted mouse induced pluripotent stem cells (iPSC).
Copyright © The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  Actinomycin D; Transcription inhibitors; mRNA decay; mRNA half-life; mRNA stability

Year:  2018        PMID: 34532533      PMCID: PMC8342049          DOI: 10.21769/BioProtoc.3072

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  6 in total

1.  Messenger RNA half-life measurements in mammalian cells.

Authors:  Chyi-Ying A Chen; Nader Ezzeddine; Ann-Bin Shyu
Journal:  Methods Enzymol       Date:  2008       Impact factor: 1.600

2.  Inhibiting eukaryotic transcription: Which compound to choose? How to evaluate its activity?

Authors:  Olivier Bensaude
Journal:  Transcription       Date:  2011-05

3.  The c-fos transcript is targeted for rapid decay by two distinct mRNA degradation pathways.

Authors:  A B Shyu; M E Greenberg; J G Belasco
Journal:  Genes Dev       Date:  1989-01       Impact factor: 11.361

4.  A comparison of apparent mRNA half-life using kinetic labeling techniques vs decay following administration of transcriptional inhibitors.

Authors:  S Harrold; C Genovese; B Kobrin; S L Morrison; C Milcarek
Journal:  Anal Biochem       Date:  1991-10       Impact factor: 3.365

5.  The RNA-binding landscapes of two SR proteins reveal unique functions and binding to diverse RNA classes.

Authors:  Minna-Liisa Änkö; Michaela Müller-McNicoll; Holger Brandl; Tomaz Curk; Crtomir Gorup; Ian Henry; Jernej Ule; Karla M Neugebauer
Journal:  Genome Biol       Date:  2012       Impact factor: 13.583

6.  SRSF3 promotes pluripotency through Nanog mRNA export and coordination of the pluripotency gene expression program.

Authors:  Madara Ratnadiwakara; Stuart K Archer; Craig I Dent; Igor Ruiz De Los Mozos; Traude H Beilharz; Anja S Knaupp; Christian M Nefzger; Jose M Polo; Minna-Liisa Anko
Journal:  Elife       Date:  2018-05-09       Impact factor: 8.140

  6 in total
  8 in total

1.  The RNA-Binding Protein HuR Posttranscriptionally Regulates the Protumorigenic Activator YAP1 in Pancreatic Ductal Adenocarcinoma.

Authors:  Samantha Z Brown; Grace A McCarthy; James R Carroll; Roberto Di Niro; Carl Pelz; Aditi Jain; Thomas L Sutton; Hannah D Holly; Avinoam Nevler; Christopher W Schultz; Matthew D McCoy; Joseph A Cozzitorto; Wei Jiang; Charles J Yeo; Dan A Dixon; Rosalie C Sears; Jonathan R Brody
Journal:  Mol Cell Biol       Date:  2022-06-15       Impact factor: 5.069

2.  Hypoxia-Reoxygenation Couples 3βHSD1 Enzyme and Cofactor Upregulation to Facilitate Androgen Biosynthesis and Hormone Therapy Resistance in Prostate Cancer.

Authors:  Liang Qin; Yoon-Mi Chung; Michael Berk; Bryan Naelitz; Ziqi Zhu; Eric Klein; Abhishek A Chakraborty; Nima Sharifi
Journal:  Cancer Res       Date:  2022-07-05       Impact factor: 13.312

3.  COX7A2L genetic variants determine cardiorespiratory fitness in mice and human.

Authors:  Giorgia Benegiamo; Maroun Bou Sleiman; Martin Wohlwend; Sandra Rodríguez-López; Ludger J E Goeminne; Pirkka-Pekka Laurila; Marie Klevjer; Minna K Salonen; Jari Lahti; Pooja Jha; Sara Cogliati; José Antonio Enriquez; Ben M Brumpton; Anja Bye; Johan G Eriksson; Johan Auwerx
Journal:  Nat Metab       Date:  2022-10-17

4.  Circular GOLPH3 RNA exerts oncogenic effects in vitro by regulating the miRNA-1299/LIF axis in oral squamous cell carcinoma.

Authors:  Chen Zou; Xia Li; Haigang Wei; Siyuan Wu; Jing Song; Zhe Tang; Hailing Luo; Xiaozhi Lv; Yilong Ai
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

5.  A novel mRNA decay inhibitor abolishes pathophysiological cellular transition.

Authors:  Daisuke Kami; Toshimasa Ishizaki; Toshihiko Taya; Akira Katoh; Hiroyuki Kouji; Satoshi Gojo
Journal:  Cell Death Discov       Date:  2022-06-07

6.  The RNA helicase DHX15 is a critical regulator of natural killer-cell homeostasis and functions.

Authors:  Guangchuan Wang; Xiang Xiao; Yixuan Wang; Xiufeng Chu; Yaling Dou; Laurie J Minze; Rafik M Ghobrial; Zhiqiang Zhang; Xian C Li
Journal:  Cell Mol Immunol       Date:  2022-03-23       Impact factor: 22.096

7.  METTL3-mediated mRNA N6-methyladenosine is required for oocyte and follicle development in mice.

Authors:  Haiyuan Mu; Ting Zhang; Ying Yang; Danru Zhang; Jie Gao; Junhong Li; Liang Yue; Dengfeng Gao; Bingbo Shi; Yue Han; Liang Zhong; Xinze Chen; Zhen-Bo Wang; Zhen Lin; Ming-Han Tong; Qing-Yuan Sun; Yun-Gui Yang; Jianyong Han
Journal:  Cell Death Dis       Date:  2021-10-23       Impact factor: 8.469

8.  NSUN6, an RNA methyltransferase of 5-mC controls glioblastoma response to temozolomide (TMZ) via NELFB and RPS6KB2 interaction.

Authors:  Chidiebere U Awah; Jan Winter; Claudiane M Mazdoom; Olorunseun O Ogunwobi
Journal:  Cancer Biol Ther       Date:  2021-10-27       Impact factor: 4.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.